For instance, resveratrol has been shown to suppress microglial activation and reduce the secretion of interleukin‐1β (IL‐1β) and tumor necrosis factor‐alpha (TNF‐α) in preclinical models of AD (Capiralla et al. 2012). The gene discussed is IL1B; the disease is Alzheimer disease.